Green · Hypertension (Dallas, Tex. : 1979) 2014 · systematic review and meta-analysis · n=20 studies (374 comparisons)

Is flow-mediated dilation nitric oxide mediated?: A meta-analysis.

Cited 360 times in the scientific literature.

Level 1 - systematic review of randomized trials

Systematic review and meta-analysis of human crossover experimental studies

PubMed 24277765 · doi:10.1161/HYPERTENSIONAHA.113.02044 · record verified 2026-08-28

What was done

A systematic review and three-stage meta-analysis of published crossover trials was performed to assess the nitric oxide (NO) dependency of human conduit artery flow-mediated dilation (FMD). Studies compared FMD under local intra-arterial infusion of saline control versus the NO synthase blocker L-NMMA. Sub-analyses examined the impact of standard protocol features (distal cuff placement, ~5-minute ischemia) and analysis techniques (automated continuous edge detection).

What was found

Across 20 studies (374 comparisons in Stage 1), FMD with saline was 8.2% (95% CI, 6.8% to 9.6%) compared with 3.7% (95% CI, 3.1% to 4.3%; P < 0.001) under L-NMMA infusion. In Stage 2 (standard distal cuff and ~5-minute occlusion in healthy volunteers), saline FMD was 6.5% (95% CI, 5.7% to 7.3%) versus 0.9% (95% CI, 0.5% to 1.3%; P < 0.001) with L-NMMA. In Stage 3 (standard protocol plus automated edge detection), saline FMD was 6.9% (95% CI, 6.0% to 7.8%) versus 2.4% (95% CI, 1.1% to 3.7%; P < 0.001) with L-NMMA.

Why it matters

This review validates flow-mediated dilation as a physiological bioassay largely dependent on endothelial nitric oxide release, reinforcing its clinical and research utility for assessing endothelial health in humans.

Limits

The abstract does not state the total count of unique human participants, only the number of studies and comparisons. Residual dilation remained despite L-NMMA blockade (ranging from 0.9% to 3.7%), indicating that non-NO vasodilatory pathways contribute to the response or that pharmacological blockade was incomplete. Specific clinical sub-populations (such as patients with cardiovascular disease) were not broken out in the abstract results.

Cited by